Comprehensive Stock Comparison
Compare MicroAlgo Inc. (MLGO) vs Synopsys, Inc. (SNPS) vs Appian Corporation (APPN) vs UiPath Inc. (PATH) vs Palladyne AI Corp. (PDYN) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | PDYN | 26.7% revenue growth vs MLGO's -9.2% |
| Value | MLGO | Better valuation composite |
| Quality / Margins | PATH | 14.8% net margin vs PDYN's -9.5% |
| Stability / Safety | MLGO | Beta 0.16 vs PDYN's 1.94 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | PDYN | +10.2% vs MLGO's -97.1% |
| Efficiency (ROA) | PATH | 7.9% ROA vs PDYN's -56.8%, ROIC -11.8% vs -84.7% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
MicroAlgo develops central processing algorithm solutions that optimize computing performance for clients in internet advertising, gaming, and intelligent chips. It generates revenue primarily through algorithm services — including optimization, data processing, and intelligence services — and secondarily through intelligent chip resale and software development. The company's competitive advantage lies in its proprietary algorithms that accelerate computing power without requiring hardware upgrades, offering cost-effective performance enhancements.
Synopsys is a leading provider of electronic design automation software and semiconductor intellectual property used to design and test integrated circuits. The company generates revenue primarily from software license sales (~60% of revenue) and maintenance/services (~40%), with its IP segment—which includes interface, analog, and security IP—growing rapidly. Its competitive moat stems from deep technical expertise, long-standing customer relationships in the complex semiconductor design ecosystem, and high switching costs for its mission-critical tools.
Appian is a low-code automation platform that enables businesses to build enterprise applications without extensive manual coding. It generates revenue primarily through subscription fees for its cloud platform — which accounts for the majority of its income — supplemented by professional services for implementation and support. The company's competitive advantage lies in its unified platform that combines process automation, case management, and data integration into a single low-code environment, creating switching costs for enterprise customers.
UiPath is a leading provider of robotic process automation (RPA) software that helps businesses automate repetitive digital tasks. The company generates revenue primarily through software licenses and cloud subscriptions — with its platform segment contributing roughly 80% of revenue — along with maintenance and support services. Its key competitive advantage lies in its comprehensive, AI-powered automation platform that combines process discovery, low-code development, and enterprise-grade management tools, creating significant switching costs for large enterprise customers.
Palladyne AI Corp. is a software company that develops artificial intelligence systems to enhance the capabilities of third-party robotic platforms. It generates revenue primarily through software licensing and subscription services for its AI/ML technology that enables robots to learn and adapt in real-time across industrial and defense applications. The company's competitive advantage lies in its proprietary foundational AI technology that allows robots to generalize from experience without extensive programming or cloud processing latency.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 5 stocks. BestLagging
Financial Scorecard
PATH leads in 1 of 6 categories (Profitability & Efficiency). PDYN leads in 1 (Total Returns). 3 tied.
Financial Metrics (TTM)
SNPS is the larger business by revenue, generating $8.0B annually — 1842.5x PDYN's $4M. PATH is the more profitable business, keeping 14.8% of every revenue dollar as net income compared to PDYN's -9.5%. On growth, SNPS holds the edge at +65.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. | APPNAppian Corporation | PATHUiPath Inc. | PDYNPalladyne AI Corp. |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $61M | $8.0B | $691M | $1.6B | $4M |
| EBITDAEarnings before interest/tax | $4M | $1.7B | $16M | $13M | -$29M |
| Net IncomeAfter-tax profit | $7M | $1.1B | -$7M | $230M | -$41M |
| Free Cash FlowCash after capex | $9M | $2.3B | $73M | $312M | -$25M |
| Gross MarginGross profit ÷ Revenue | +26.8% | +75.1% | +76.3% | +83.2% | +57.6% |
| Operating MarginEBIT ÷ Revenue | +5.8% | +10.8% | +0.9% | +0.6% | -6.8% |
| Net MarginNet income ÷ Revenue | +11.1% | +13.8% | -1.1% | +14.8% | -9.5% |
| FCF MarginFCF ÷ Revenue | +14.9% | +28.5% | +10.5% | +20.1% | -5.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -34.3% | +65.5% | +21.4% | +15.9% | -1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -8.2% | -78.8% | +4.4% | +19.5% | +66.7% |
Valuation Metrics
At 6.5x trailing earnings, MLGO trades at a 100% valuation discount to APPN's 1333.5x P/E. On an enterprise value basis, SNPS's 57.6x EV/EBITDA is more attractive than APPN's 3494.0x.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. | APPNAppian Corporation | PATHUiPath Inc. | PDYNPalladyne AI Corp. |
|---|---|---|---|---|---|
| Market CapShares × price | $36M | $79.3B | $2.0B | $797M | $296M |
| Enterprise ValueMkt cap + debt − cash | -$85M | $90.7B | $2.1B | -$5M | $275M |
| Trailing P/EPrice ÷ TTM EPS | 6.49x | 51.49x | 1333.50x | -82.54x | -2.54x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 28.67x | 30.06x | 15.98x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 3.82x | — | — | — |
| EV / EBITDAEnterprise value multiple | -30.45x | 57.55x | 3494.04x | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.48x | 11.24x | 2.71x | 0.56x | 37.95x |
| Price / BookPrice ÷ Book value/share | 0.23x | 2.36x | — | 3.26x | — |
| Price / FCFMarket cap ÷ FCF | 8.77x | 58.75x | 33.14x | 2.61x | — |
Profitability & Efficiency
PATH delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-80 for PDYN. PATH carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNPS's 0.50x. On the Piotroski fundamental quality scale (0–9), APPN scores 6/9 vs SNPS's 3/9, reflecting solid financial health.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. | APPNAppian Corporation | PATHUiPath Inc. | PDYNPalladyne AI Corp. |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.1% | +3.6% | — | +11.9% | -79.9% |
| ROA (TTM)Return on assets | +2.1% | +2.3% | -1.2% | +7.9% | -56.8% |
| ROICReturn on invested capital | +14.1% | +3.0% | +0.3% | -11.8% | -84.7% |
| ROCEReturn on capital employed | +2.9% | +3.3% | +0.2% | -7.5% | -51.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.16x | 0.50x | — | 0.04x | — |
| Net DebtTotal debt minus cash | -$121M | $11.4B | $154M | -$801M | -$20M |
| Cash & Equiv.Liquid assets | $144M | $2.9B | $136M | $880M | $31M |
| Total DebtShort + long-term debt | $23M | $14.3B | $290M | $78M | $11M |
| Interest CoverageEBIT ÷ Interest expense | 25.26x | 6.38x | 0.85x | — | — |
Total Returns (with DRIP)
A $10,000 investment in SNPS five years ago would be worth $16,288 today (with dividends reinvested), compared to $1 for MLGO. Over the past 12 months, PDYN leads with a +10.2% total return vs MLGO's -97.1%. The 3-year compound annual growth rate (CAGR) favors PDYN at 23.0% vs MLGO's -93.3% — a key indicator of consistent wealth creation.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. | APPNAppian Corporation | PATHUiPath Inc. | PDYNPalladyne AI Corp. |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.3% | -13.8% | -21.7% | -32.4% | +48.9% |
| 1-Year ReturnPast 12 months | -97.1% | -9.5% | -17.9% | -12.8% | +10.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | +13.8% | -35.7% | -27.7% | +86.0% |
| 5-Year ReturnCumulative with dividends | -100.0% | +62.9% | -85.7% | -84.4% | -87.1% |
| 10-Year ReturnCumulative with dividends | -100.0% | +825.1% | +77.7% | -84.4% | -87.1% |
| CAGR (3Y)Annualised 3-year return | -93.3% | +4.4% | -13.7% | -10.2% | +23.0% |
Risk & Volatility
MLGO is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than PDYN's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SNPS currently trades 63.5% from its 52-week high vs MLGO's 0.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. | APPNAppian Corporation | PATHUiPath Inc. | PDYNPalladyne AI Corp. |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.16x | 1.37x | 1.03x | 1.34x | 1.94x |
| 52-Week HighHighest price in past year | $972.00 | $651.73 | $46.06 | $19.84 | $13.00 |
| 52-Week LowLowest price in past year | $3.35 | $365.74 | $21.77 | $9.38 | $4.14 |
| % of 52W HighCurrent price vs 52-week peak | +0.4% | +63.5% | +57.9% | +54.1% | +54.1% |
| RSI (14)Momentum oscillator 0–100 | 41.8 | 42.9 | 52.7 | 36.0 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 149K | 1.7M | 915K | 24.5M | 3.8M |
Analyst Outlook
Analyst consensus: SNPS as "Buy", APPN as "Hold", PATH as "Hold". Consensus price targets imply 51.9% upside for PATH (target: $16) vs 13.4% for APPN (target: $30).
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. | APPNAppian Corporation | PATHUiPath Inc. | PDYNPalladyne AI Corp. |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | — |
| Price TargetConsensus 12-month target | — | $529.44 | $30.25 | $16.30 | — |
| # AnalystsCovering analysts | — | 27 | 19 | 24 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.0% | +49.0% | +0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Oct 21 | Feb 26 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | 100 | 0.01 | -100.0% |
| Synopsys, Inc. (SNPS) | 100 | 151.37 | +51.4% |
| Appian Corporation (APPN) | 100 | 28.33 | -71.7% |
| UiPath Inc. (PATH) | 100 | 24.04 | -76.0% |
| Palladyne AI Corp. (PDYN) | 80.66 | 12.49 | -84.5% |
Synopsys, Inc. (SNPS) returned +63% over 5 years vs MicroAlgo Inc. (MLGO)'s -100%. A $10,000 investment in SNPS 5 years ago would be worth $16,288 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | $16M | $74M | +364.6% |
| Synopsys, Inc. (SNPS) | $2.4B | $7.1B | +191.2% |
| Appian Corporation (APPN) | $133M | $727M | +446.9% |
| UiPath Inc. (PATH) | $336M | $1.4B | +325.3% |
| Palladyne AI Corp. (PDYN) | $9M | $8M | -11.7% |
Synopsys, Inc.'s revenue grew from $2.4B (2016) to $7.1B (2025) — a 12.6% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | 39.0% | 7.1% | -81.7% |
| Synopsys, Inc. (SNPS) | 11.0% | 18.9% | +71.5% |
| Appian Corporation (APPN) | -9.4% | 0.2% | +101.8% |
| UiPath Inc. (PATH) | -154.7% | -5.2% | +96.7% |
| Palladyne AI Corp. (PDYN) | -2.4% | -9.3% | -292.8% |
Synopsys, Inc.'s net margin went from 11% (2016) to 19% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | 96.9 | 58.4 | -39.7% |
Synopsys, Inc. has traded in a 30x–97x P/E range over 9 years; current trailing P/E is ~51x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | 29.45 | 0.55 | -98.1% |
| Synopsys, Inc. (SNPS) | 1.73 | 8.04 | +364.7% |
| Appian Corporation (APPN) | -0.23 | 0.02 | +108.7% |
| UiPath Inc. (PATH) | -1 | -0.13 | +87.0% |
| Palladyne AI Corp. (PDYN) | -1.21 | -2.77 | -128.9% |
Synopsys, Inc.'s EPS grew from $1.73 (2016) to $8.04 (2025) — a 19% CAGR.
Chart 6Free Cash Flow — 5 Years
MicroAlgo Inc. generated $4M FCF in 2024 (-74% vs 2021). Synopsys, Inc. generated $1B FCF in 2025 (-3% vs 2021).
MLGO vs SNPS vs APPN vs PATH vs PDYN: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is MLGO or SNPS or APPN or PATH or PDYN a better buy right now?
MicroAlgo Inc. (MLGO) offers the better valuation at 6.5x trailing P/E, making it the more compelling value choice. Analysts rate Synopsys, Inc. (SNPS) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MLGO or SNPS or APPN or PATH or PDYN?
On trailing P/E, MicroAlgo Inc. (MLGO) is the cheapest at 6.5x versus Appian Corporation at 1333.5x. On forward P/E, UiPath Inc. is actually cheaper at 16.0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MLGO or SNPS or APPN or PATH or PDYN?
Over the past 5 years, Synopsys, Inc. (SNPS) delivered a total return of +62.9%, compared to -100.0% for MicroAlgo Inc. (MLGO). A $10,000 investment in SNPS five years ago would be worth approximately $16K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SNPS returned +825.1% versus MLGO's -100.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MLGO or SNPS or APPN or PATH or PDYN?
By beta (market sensitivity over 5 years), MicroAlgo Inc. (MLGO) is the lower-risk stock at 0.16β versus Palladyne AI Corp.'s 1.94β — meaning PDYN is approximately 1130% more volatile than MLGO relative to the S&P 500. On balance sheet safety, UiPath Inc. (PATH) carries a lower debt/equity ratio of 4% versus 50% for Synopsys, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — MLGO or SNPS or APPN or PATH or PDYN?
Synopsys, Inc. (SNPS) is the more profitable company, earning 18.9% net margin versus -932.7% for Palladyne AI Corp. — meaning it keeps 18.9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNPS leads at 13.0% versus -345.8% for PDYN. At the gross margin level — before operating expenses — PATH leads at 82.7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is MLGO or SNPS or APPN or PATH or PDYN more undervalued right now?
On forward earnings alone, UiPath Inc. (PATH) trades at 16.0x forward P/E versus 30.1x for Appian Corporation — 14.1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PATH: 51.9% to $16.30.
07Which pays a better dividend — MLGO or SNPS or APPN or PATH or PDYN?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is MLGO or SNPS or APPN or PATH or PDYN better for a retirement portfolio?
For long-horizon retirement investors, MicroAlgo Inc. (MLGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.16)). Palladyne AI Corp. (PDYN) carries a higher beta of 1.94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MLGO: -100.0%, PDYN: -87.1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MLGO and SNPS and APPN and PATH and PDYN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: MLGO is a small-cap deep-value stock; SNPS is a mid-cap quality compounder stock; APPN is a small-cap quality compounder stock; PATH is a small-cap quality compounder stock; PDYN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.